期刊文献+

人胶质瘤细胞株SWO-38异质性蛋白质分子机制的研究

Study on the Protein Mechanism of Tumor Heterogeneity of Glioma Cell Line SWO-38
下载PDF
导出
摘要 胶质瘤是成人颅内最常见的恶性肿瘤。本研究探讨人胶质瘤细胞SWO-38两亚株(SWOZ1和SWOZ2)异质性的蛋白质分子机制。方法:采用Western blot法检测SWO-38及其两亚株中鼠双微粒体基因-2(Murine double minute-2,MDM2)的表达情况;应用免疫共沉淀技术检测两亚株中MDM2相关蛋白的表达情况。结果:在SWO-38及其两亚株中均能检测到MDM2的表达,在其免疫共沉淀物中,Mr 37000处有一蛋白条带在SWOZ2中比在SWOZ1中明显深染。结论:人胶质瘤细胞SWO-38的两亚株,在MDM2传导通路中于Mr约37000处的某蛋白表达量不同,而此差异蛋白可能与胶质瘤异质性的产生密切相关。 BACKGROUND & OBJECTIVE: Glioma is the most common brain tumor in adult. This study was undertaken to investigate the protein molecular mechanism of tumor heterogeneity of gliomas with two sublines(SWOZ1 and SWOZ2) of SWO-38.METHODS: MDM2 expression in SWO-38 and its two sublines were determined by using Western blot analysis. Then, co-im-munoprecipitation method was used to exam the expression of MDM2 binding proteins in two sublines. RESULTS: Expression of MDM2 was observed in all SWO-38 and its two sublines, and there was a major difference between two sublines in the MDM2' S immuno-precipitation compond which was in the protein molecule weight of 37000. CONCLUSION: The difference in the MDM2 transmit channel protein with molecule weight of 37000 between two sublines of SWO -38 may associated with heterogeneity of the gliomas.
出处 《中国神经肿瘤杂志》 2003年第4期205-208,共4页 Chinese Journal of Neuro-Oncology
基金 国家"973"重大基础研究资助项目(No.2002ccc00400) 广东省科技攻关项目(No.2003B3010)
关键词 胶质瘤 异质性 MDM2 Gliotna Heterogeneity MDM2
  • 相关文献

参考文献6

  • 1李文东,刘芝华.HDM2和p53蛋白的相互作用及其抑制剂的研究[J].国外医学(肿瘤学分册),2002,29(4):255-258. 被引量:5
  • 2Linda Cahilly-Snyder,Teresa Yang-Feng,Uta Francke,Donna L. George.Molecular analysis and chromosomal mapping of amplified genes isolated from a transformed mouse 3T3 cell line[J]. Somatic Cell and Molecular Genetics . 1987 (3)
  • 3Zhong XY,Chen YX,Ye SF, et al.Establishment of two cell subline from SWO-38 glioma cell: an immunohisto-chemical and ultrastructural Study. Int Mod Cancer Thera . 2000
  • 4Cahilly Snyder L,Yang Feng T,Francke U, et al.Molecular analysis and chromosomal mapping of amplified genes isolated from a transformed mouse 3T3 cell line. Somatic Cell and Molecular Genetics . 1987
  • 5Hepper Gh.Tumor heterogeneity. Cancer Research . 1984
  • 6McCann AH,Kirlcy A,Carncy DN,et al.Amplification of the MDM2 gene in human brest cancer and its association with MDM2 and p53 status. British Journal of Cancer . 1995

二级参考文献14

  • 1Juven Gershon T, Oren M. Mdm2 : the ups and downs [J]. Mol Med, 1999, 5(2): 71-83.
  • 2Momand J, Jung D, Wilczynski S, et al. The MDM2 gene amplification database[J]. Nucleic Acids Res, 1998, 26(15): 3453-3459.
  • 3Garcia Echeverria C, Chene P, Blommers MJ, et al. Discovery of potent antagonists of the interaction between human double minute 2 and tumor suppressor p53[J]. J Med Chem, 2000, 43(17): 3205-3208.
  • 4Mayo LD, Turchi JJ, Berberich SJ. Mdm-2 phosphorylation by DNA-dependent protein kinase prevents interaction with p53[J]. Cancer Res, 1997, 57(22): 5013-5016.
  • 5Zhang Y, Xiong Y, Yarbrough WG. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways[J]. Cell, 1998, 92(6): 725-734.
  • 6Lane DP, Hall PA. MDM2-arbiter of p53's destruction[J]. Trends Biochem Sci, 1997, 22(10): 372-374.
  • 7Bottger A, Bottger V, Garcia Echeverria C, et al. Molecular characterization of the hdm2-p53 interaction[J]. J Mol Biol, 1997, 269(5): 744-756.
  • 8Blaydes Jp, Gire V, Rowson JM, et al. Tolerance of high levels of wild-type p53 in transformed epithelial cells dependent on auto-regu-lation by mdm-2[J]. Oncogene, 1997, 14(15): 1859-1868.
  • 9Wasylyk C, Salvi R, Argentini M, et al. p53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53[J]. Oncogene, 1999, 18(11): 1921-1934.
  • 10Chen L, Agrawal S, Zhou W, et al. Synergistic activation of p53 by inhibition of MDM2 expression and DNA damage[J]. Proc Natl Acad Sci USA, 1998, 95(1): 195-200.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部